← All trials
NCT06015230
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 8, 2022
- Primary completion
- Jun 10, 2028
- Completion date
- Oct 4, 2028
- First posted
- Aug 29, 2023
- Last posted
- Aug 29, 2023
- Enrollment
- 136
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
- Chinese Academy of Medical SciencesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.